AVAH vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

AVAH

47.7
AI Score
VS
AVAH Wins

MD

37.9
AI Score

Investment Advisor Scores

AVAH

48score
Recommendation
HOLD

MD

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AVAH MD Winner
Net Income 225,034 116.41M MD
Operating Income 256.46M 163.79M AVAH
ROE 0.1% 13.7% MD
ROA 0.0% 5.4% MD
Total Assets 2.01B 2.14B MD
Cash 193.26M 311.92M MD
Debt/Equity 6.68 0.72 MD
Current Ratio 1.32 1.28 AVAH

Relative Price Performance (Last 90 Days)

AVAH 1M: +7.5% · 3M: +15.9% MD 1M: +18.2% · 3M: +19.3%

Current Technical Phase

AVAH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 51

RSI (14): 50.7 · Price: $13.09

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.9% over 20 days), RSI 67

RSI (14): 66.7 · Price: $31.45

Fundamentals Snapshot

Metric AVAH MD
Market Cap — —
Forward P/E 14.4 12.7
Trailing P/E 10.5 17.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.1%
EPS 1.26 1.83
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AVAH is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.